VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Terns Pharmaceuticals, Inc. (TERN) Total Return Calculator with Dividends Reinvested

Terns Pharmaceuticals, Inc.

Popular:

The total return for Terns Pharmaceuticals, Inc. (TERN) stock is +1659.70% over the past 12 months. So far it's up 32.05% this year. The 5-year total return is +229.81%, meaning $10,000 invested in TERN stock 5 years ago would be worth $32,981 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in TERN 1 year ago, it would be worth $175,970 today — you'd have gained $165,970.

With Dividends Reinvested$175,970+1659.70%

Price Only (No DRIP)$175,970+1659.70%

Period2025-05-06 → 2026-05-04

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in TERN

1Y$175,970+$165,970 (+1659.7%)1659.7% CAGR

3Y$40,279+$30,279 (+302.8%)59.1% CAGR

5Y$32,981+$22,981 (+229.8%)27.0% CAGR

10Y$28,802+$18,802 (+188.0%)11.2% CAGR

15Y$28,802+$18,802 (+188.0%)7.3% CAGR

20Y$28,802+$18,802 (+188.0%)5.4% CAGR

30Y$28,802+$18,802 (+188.0%)3.6% CAGR

Terns Pharmaceuticals, Inc. did not pay dividends during this period. Total return = price return.

Loading TERN total return...

As of 2026-05-06

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+32.05%	—	+32.05%	—	$13,205
1Y	+1659.70%	1659.70%	+1659.70%	—	$175,970
3Y	+302.79%	59.11%	+302.79%	—	$40,279
5Y	+229.81%	26.96%	+229.81%	—	$32,981
10Y	+188.02%	11.16%	+188.02%	—	$28,802
15Y	+188.02%	7.31%	+188.02%	—	$28,802
20Y	+188.02%	5.43%	+188.02%	—	$28,802
30Y	+188.02%	3.59%	+188.02%	—	$28,802

Risk & Highlights

Best Year+612.52%2025

Worst Year-61.56%2021

Max Drawdown-27.56%2025-12-11 → 2026-01-12 · Recovered 2026-03-18

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+5.01%	+5.01%	—	+0.41%	+4.6pp
2025	+612.52%	+612.52%	—	+16.64%	+595.9pp
2024	-14.51%	-14.51%	—	+24.00%	-38.5pp
2023	-26.08%	-26.08%	—	+24.81%	-50.9pp
2022	+51.94%	+51.94%	—	-19.95%	+71.9pp

TERN outperformed the S&P 500 by 1628.38pp over the past year (+1659.70% vs +31.32%).

Loading summary...

TERN Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
TERNTerns Pharmaceuticals, Inc.	$4.6B	+0.4%	+32.1%	+1659.7%	—	+302.8%	+229.8%	+188.0%
MDGLMadrigal Pharmaceuticals, Inc.	$12.4B	+1.1%	-9.1%	+82.9%	—	+74.7%	+326.0%	+3755.2%
AKROAkero Therapeutics, Inc.	$4.5B	—	—	+30.1%	—	+20.1%	+107.2%	+198.3%
HIMSHims & Hers Health, Inc.	$6.9B	+32.2%	-19.5%	-45.7%	—	+126.8%	+150.5%	+174.3%
ELVNEnliven Therapeutics, Inc.	$2.4B	+5.8%	+165.1%	+109.2%	—	+115.3%	+44.9%	-31.3%
GPCRStructure Therapeutics Inc.	$2.4B	-21.1%	-40.0%	+61.2%	—	+70.2%	+57.1%	+57.1%
VKTXViking Therapeutics, Inc.	$3.7B	-4.9%	-8.9%	+19.5%	—	+41.2%	+459.4%	+2503.2%
ARWRArrowhead Pharmaceuticals, Inc.	$11.1B	+29.5%	+16.7%	+505.0%	—	+95.6%	+20.5%	+1315.7%
ALDXAldeyra Therapeutics, Inc.	$105M	+14.5%	-62.7%	-17.1%	—	-83.7%	-85.6%	-71.9%
HALOHalozyme Therapeutics, Inc.	$7.8B	+5.2%	-5.6%	+11.7%	—	+119.1%	+39.1%	+598.4%
INVAInnoviva, Inc.	$1.9B	-2.2%	+13.3%	+20.4%	—	+92.8%	+95.5%	+90.5%

Compare:TERN vs MDGL TERN vs AKRO TERN vs HIMS TERN vs MDGL vs AKRO

About TERN Dividend Returns

Terns Pharmaceuticals, Inc. (TERN) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of TERN over the past year?

Terns Pharmaceuticals, Inc. (TERN) delivered a return of 1659.70% over the past year. Since TERN does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in TERN be worth today?

A $10,000 investment in Terns Pharmaceuticals, Inc. one year ago would be worth $175,970 today, representing a gain of $165,970.

Q3Does TERN pay dividends?

Terns Pharmaceuticals, Inc. (TERN) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For TERN, the total return equals the price-only return.

Q4Did TERN beat the S&P 500?

Yes, Terns Pharmaceuticals, Inc. (TERN) outperformed the S&P 500 by 1628.38 percentage points over the past year. TERN delivered a total return of 1659.70%, compared to the S&P 500's 31.32%. This 1628.38pp alpha means investors in TERN earned more than a passive S&P 500 index fund.

Q5What is TERN's worst drawdown?

Terns Pharmaceuticals, Inc. (TERN) experienced a maximum drawdown of -27.56% over the past year, declining from its peak on 2025-12-11 to its trough on 2026-01-12. The stock recovered to its prior peak by 2026-03-18. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is TERN's long-term total return over 10, 20, or 30 years?

Here are Terns Pharmaceuticals, Inc. (TERN)'s long-term returns with dividends reinvested. Over 10 years, the total return is 188.0% (11.2% CAGR) — $10,000 would have grown to $28,802. Over 20 years: 188.0% total return (5.4% CAGR) — $10,000 → $28,802. Over 30 years: 188.0% total return (3.6% CAGR) — $10,000 → $28,802. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was TERN's best and worst year?

Terns Pharmaceuticals, Inc.'s best calendar year was 2025 with a total return of 612.5%. Its worst year was 2021 with a total return of -61.6%. This range shows the volatility investors should expect — the difference between the best and worst year is 674.1 percentage points.